Sector

Real Estate

56 companies under coverage across 14 industries.

Industries

Browse by industry

Data Center REITs 2 Diversified REITs 1 Health Care REITs 8 Hotel & Resort REITs 3 Industrial REITs 6 Multi-Family Residential REITs 5 Office REITs 6 Other Specialized REITs 4 Real Estate Services 3 Retail REITs 8 Self-Storage REITs 2 Single-Family Residential REITs 3 Telecom Tower REITs 3 Timber REITs 2

Coverage

Real Estate companies

Equity Research

Weyerhaeuser Company (WY)

BUY. 12-month probability-weighted target $25 (+29% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

WYEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +27.2%

Equity Research

Agree Realty Corporation (ADC)

BUY. 12-month probability-weighted target $82 (+25% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADCEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +20.8%

Equity Research

Healthcare Realty Trust Incorporated (HR)

BUY. 12-month probability-weighted target $21 (+23% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +18.8%

Equity Research

W P Carey Inc (WPC)

BUY. 12-month probability-weighted target $76 (+20% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

WPCEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.4%

Equity Research

Brixmor Property (BRX)

BUY. 12-month probability-weighted target $33 (+20% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BRXEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.4%

Equity Research

Alexandria Real Estate Equities Inc (ARE)

BUY. 12-month probability-weighted target $55 (+20% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

AREEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.4%

Equity Research

Kite Realty Group Trust (KRG)

BUY. 12-month probability-weighted target $30 (+25% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

KRGEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.1%

Equity Research

Mid-America Apartment Communities Inc (MAA)

BUY. 12-month probability-weighted target $141 (+20% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MAAEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.0%

Equity Research

NNN REIT, Inc. (NNN)

BUY. 12-month probability-weighted target $48 (+19% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

NNNEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +15.8%

Equity Research

Cousins Properties Incorporated (CUZ)

BUY. 12-month probability-weighted target $33 (+18% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CUZEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +15.7%

Equity Research

UDR Inc (UDR)

BUY. 12-month probability-weighted target $40 (+18% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

UDREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +15.0%

Equity Research

Realty Income Corporation (O)

BUY. 12-month probability-weighted target $63 (+17% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +14.7%

Equity Research

STAG Industrial Inc (STAG)

BUY. 12-month probability-weighted target $43 (+18% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

STAGEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +14.0%

Equity Research

Host Hotels & Resorts Inc (HST)

BUY. 12-month probability-weighted target $27 (+17% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HSTEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +13.9%

Equity Research

CareTrust REIT Inc. (CTRE)

HOLD. 12-month probability-weighted target $42 (+16% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

CTREEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +13.3%

Equity Research

EPR Properties (EPR)

HOLD. 12-month probability-weighted target $63 (+16% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

EPREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +12.1%

Equity Research

Independence Realty Trust Inc (IRT)

BUY. 12-month probability-weighted target $17 (+15% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

IRTEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +11.5%

Equity Research

Kilroy Realty Corp (KRC)

HOLD. 12-month probability-weighted target $39 (+13% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

KRCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +11.0%

Equity Research

VICI Properties Inc (VICI)

HOLD. 12-month probability-weighted target $26 (+13% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

VICIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +10.7%

Equity Research

Regency Centers Corporation (REG)

HOLD. 12-month probability-weighted target $82 (+14% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

REGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +10.2%

Equity Research

Public Storage (PSA)

BUY. 12-month probability-weighted target $330 (+14% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PSAEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +10.2%

Equity Research

First Industrial Realty Trust Inc (FR)

HOLD. 12-month probability-weighted target $67 (+14% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +9.6%

Equity Research

BXP, Inc. (BXP)

HOLD. 12-month probability-weighted target $67 (+13% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

BXPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +9.2%

Equity Research

EastGroup Properties Inc (EGP)

HOLD. 12-month probability-weighted target $220 (+12% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

EGPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +8.4%

Equity Research

Essex Property Trust Inc (ESS)

HOLD. 12-month probability-weighted target $303 (+12% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ESSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +7.5%

Equity Research

Ventas Inc (VTR)

HOLD. 12-month probability-weighted target $92 (+12% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

VTREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.9%

Equity Research

Extra Space Storage Inc (EXR)

HOLD. 12-month probability-weighted target $148 (+10% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

EXREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.2%

Equity Research

Healthpeak Properties Inc (DOC)

HOLD. 12-month probability-weighted target $21 (+10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

DOCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.2%

Equity Research

COPT Defense Properties (CDP)

HOLD. 12-month probability-weighted target $36 (+8% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CDPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.1%

Equity Research

Prologis Inc (PLD)

HOLD. 12-month probability-weighted target $139 (+8% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

PLDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.8%

Equity Research

Rayonier Inc (RYN)

BUY. 12-month probability-weighted target $22 (+16% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

RYNEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +5.5%

Equity Research

Welltower Inc (WELL)

HOLD. 12-month probability-weighted target $241 (+7% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

WELLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.4%

Equity Research

Digital Realty Trust Inc (DLR)

HOLD. 12-month probability-weighted target $196 (+9% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.4%

Equity Research

Simon Property Group Inc (SPG)

BUY. 12-month probability-weighted target $232 (+17% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SPGEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +5.2%

Equity Research

Lamar Advertising Company (LAMR)

HOLD. 12-month probability-weighted target $157 (+8% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

LAMREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.2%

Equity Research

Invitation Homes Inc (INVH)

HOLD. 12-month probability-weighted target $29 (+8% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

INVHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.8%

Equity Research

CubeSmart (CUBE)

HOLD. 12-month probability-weighted target $41 (+9% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

CUBEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.8%

Equity Research

Equity Lifestyle Properties Inc (ELS)

HOLD. 12-month probability-weighted target $64 (+8% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

ELSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.4%

Equity Research

American Homes 4 Rent (AMH)

HOLD. 12-month probability-weighted target $33 (+7% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

AMHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +3.9%

Equity Research

CoStar Group Inc (CSGP)

HOLD. 12-month probability-weighted target $30 (+0% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

CSGPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +3.4%

Equity Research

Sabra Healthcare REIT Inc (SBRA)

HOLD. 12-month probability-weighted target $20 (+3% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SBRAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.4%

Equity Research

Equinix Inc (EQIX)

HOLD. 12-month probability-weighted target $1049 (+2% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

EQIXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.7%

Equity Research

Jones Lang LaSalle Incorporated (JLL)

HOLD. 12-month probability-weighted target $326 (+9% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

JLLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.2%

Equity Research

Rexford Industrial Realty Inc (REXR)

HOLD. 12-month probability-weighted target $37 (+2% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

REXREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.6%

Equity Research

Crown Castle (CCI)

HOLD. 12-month probability-weighted target $80 (+0% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

CCIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.0%

Equity Research

SBA Communications Corp (SBAC)

HOLD. 12-month probability-weighted target $178 (-3% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

SBACEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.5%

Equity Research

CBRE Group Inc Class A (CBRE)

HOLD. 12-month probability-weighted target $133 (+2% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

CBREEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.7%

Equity Research

American Tower Corp (AMT)

HOLD. 12-month probability-weighted target $173 (-5% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AMTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.3%

Equity Research

Park Hotels & Resorts Inc (PK)

HOLD. 12-month probability-weighted target $15 (-4% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

PKEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.4%

Equity Research

American Healthcare REIT, Inc. (AHR)

HOLD. 12-month probability-weighted target $47 (-8% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AHREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.3%

Equity Research

Iron Mountain Incorporated (IRM)

SELL. 12-month probability-weighted target $97 (-15% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

IRMEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -17.1%

Equity Research

Omega Healthcare Investors Inc (OHI)

Rating suspended since 2026-10-02 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

OHIEquity ResearchMonte Carlo

2 October 2026Rating: N/A

Equity Research

Gaming & Leisure Properties (GLPI)

Rating suspended since 2026-10-02 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

GLPIEquity ResearchMonte Carlo

2 October 2026Rating: N/A

Equity Research

Vornado Realty Trust (VNO)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

VNOEquity ResearchMonte Carlo

1 October 2026Rating: N/A

Equity Research

Federal Realty Investment Trust (FRT)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

FRTEquity ResearchMonte Carlo

1 October 2026Rating: N/A

Equity Research

Camden Property Trust (CPT)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

CPTEquity ResearchMonte Carlo

1 October 2026Rating: N/A